Artículo
Repurposing of host-based therapeutic agents for the treatment of coronavirus disease 2019 (COVID-19): a link between antiviral and anticancer mechanisms?
Fecha de publicación:
09/2020
Editorial:
Elsevier Science
Revista:
International Journal of Antimicrobial Agents
ISSN:
0924-8579
Idioma:
Inglés
Tipo de recurso:
Artículo publicado
Clasificación temática:
Resumen
Drug repurposing, also called repositioning or rediscovering, refers to the process of developing a known drug for a novel use that is different from its original clinical indication. This concept has focused great attention on the search for viable treatments in the context of the current coronavirus disease 2019 (COVID-19) pandemic.
Palabras clave:
DRUG REPURPOSING
,
IVERMECTIN
,
STATINS
,
COVID-19
Archivos asociados
Licencia
Identificadores
Colecciones
Articulos(SEDE CENTRAL)
Articulos de SEDE CENTRAL
Articulos de SEDE CENTRAL
Citación
Alonso, Daniel Fernando; Farina, Hernán Gabriel; Repurposing of host-based therapeutic agents for the treatment of coronavirus disease 2019 (COVID-19): a link between antiviral and anticancer mechanisms?; Elsevier Science; International Journal of Antimicrobial Agents; 56; 3; 9-2020; 1-3
Compartir
Altmétricas